Marschall, Jonas; Carpenter, C. R.; Fowler, S.; Trautner, B. W. (2013). Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ, 346(jun11 1), f3147-f3147. BMJ Publishing Group 10.1136/bmj.f3147
|
Text
bmj.f3147.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (463kB) | Preview |
Abstract
Objective To determine whether antibiotic prophylaxis at the time of removal of a urinary catheter reduces the risk of subsequent symptomatic urinary tract infection.
Design Systematic review and meta-analysis of studies published before November 2012 identified through PubMed, Embase, Scopus, and the Cochrane Library; conference abstracts for 2006-12 were also reviewed.
Inclusion criteria Studies were included if they examined antibiotic prophylaxis administered to prevent symptomatic urinary tract infection after removal of a short term (≤14 days) urinary catheter.
Results Seven controlled studies had symptomatic urinary tract infection after catheter removal as an endpoint; six were randomized controlled trials (five published; one in abstract form) and one was a non-randomized controlled intervention study. Five of these seven studies were in surgical patients. Studies were heterogeneous in the type and duration of antimicrobial prophylaxis and the period of observation. Overall, antibiotic prophylaxis was associated with benefit to the patient, with an absolute reduction in risk of urinary tract infection of 5.8% between intervention and control groups. The risk ratio was 0.45 (95% confidence interval 0.28 to 0.72). The number needed to treat to prevent one urinary tract infection was 17 (12 to 30).
Conclusions Patients admitted to hospital who undergo short term urinary catheterization might benefit from antimicrobial prophylaxis when the catheter is removed as they experience fewer subsequent urinary tract infections. Potential disadvantages of more widespread antimicrobial prophylaxis (side effects and cost of antibiotics, development of antimicrobial resistance) might be mitigated by the identification of which patients are most likely to benefit from this approach.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Marschall, Jonas |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1756-1833 |
Publisher: |
BMJ Publishing Group |
Language: |
English |
Submitter: |
Annelies Luginbühl |
Date Deposited: |
21 Mar 2014 10:39 |
Last Modified: |
05 Dec 2022 14:29 |
Publisher DOI: |
10.1136/bmj.f3147 |
BORIS DOI: |
10.7892/boris.44229 |
URI: |
https://boris.unibe.ch/id/eprint/44229 |